CDX1 and central nervous system cancer: In the article of Lei et al., they suggested miR-24 could promote glioma progression through CDX1/PI3K/Akt signaling pathway, indicating a novel pathway underlying progression in glioma cells and providing a potential target for glioma treatment [15].